Revolutionizing drug development for Parkinson's disease by using imaging biomarkers analysis tools.
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
Prof. Russ Hornbeck shares insights on Alzheimer's research and imaging technology through his experience in medical imaging, discussing the DIAN...
For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’
At RSNA 2022, our team discussed the latest advances in imaging trials software, including state-of-the-art digital biomarkers algorithms.
In order to assure that QMENTA is a reliable trusted partner for managing your medical data, we follow the highest security standards.
Since the discovery of X-Rays in 1895, Radiology has been evolving rapidly. With 127 years of advancements in mind, what can we expect for its future?
Companies and technicians that are developing new algorithms to help researches and professionals to diagnose and measure diseases progression...
The neuro tech field has sped up in recent years and staying on top of trends is becoming a must in the neuro research. Choosing the right tech when...
Boston, MA, 29/11/21 QMENTA announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for...